Nothing Special   »   [go: up one dir, main page]

Jump to content

Spiramide

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by PotatoBot (talk | contribs) at 17:24, 29 July 2010 (Stub sorting and placement of stub template(s)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Spiramide
Clinical data
ATC code
  • none
Identifiers
  • 8-[3-(4-Fluorophenoxy)propyl]-1-phenyl-1,3,8-triazaspiro[4,5]decan-4-one
CAS Number
PubChem CID
IUPHAR/BPS
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC22H27FN3O2
Molar mass384.466 g/mol g·mol−1
3D model (JSmol)
  • c2cc(F)ccc2OCCCN3CCC1(CC3)N(CNC1=O)c4ccccc4

Spiramide (AMI-193) is a a selective 5-HT2A, 5-HT1A, and D2 receptor antagonist. It has negligible affinity for the 5-HT2C receptor.[1][2][3]

References

  1. ^ Czoty PW, Howell LL (2000). "Behavioral effects of AMI-193, a 5-HT(2A)- and dopamine D(2)-receptor antagonist, in the squirrel monkey". Pharmacology, Biochemistry, and Behavior. 67 (2): 257–64. PMID 11124389. {{cite journal}}: Unknown parameter |month= ignored (help)
  2. ^ Luparini MR, Garrone B, Pazzagli M, Pinza M, Pepeu G (2004). "A cortical GABA-5HT interaction in the mechanism of action of the antidepressant trazodone". Progress in Neuro-psychopharmacology & Biological Psychiatry. 28 (7): 1117–27. doi:10.1016/j.pnpbp.2004.05.046. PMID 15610924. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  3. ^ Hamada K, Yoshida M, Isayama H, Yagi Y, Kanazashi S, Kashihara Y, Takeuchi K, Yamaguchi I (2007). "Possible involvement of endogenous 5-HT in aggravation of cerulein-induced acute pancreatitis in mice". Journal of Pharmacological Sciences. 105 (3): 240–50. PMID 17965538. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)